Czechia – Antineoplastic and immunomodulating agents – „Dodávky léků – Tocilizumab 2024 - biosimilar
Revmatologický ústav awarded Kč96.1M to Fresenius Kabi s.r.o. for Professional Services & Consulting in August 2024 — one of 49 awards this buyer has made, above its typical award size.
Buying agency
Revmatologický ústavWinning supplier
Fresenius Kabi s.r.o.Contract description
Czechia – Antineoplastic and immunomodulating agents – „Dodávky léků – Tocilizumab 2024 - biosimilar
Related awards · Revmatologický ústav
49 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-532761-2025Alliance Healthcare s.r.o.Kč151M14 Aug 2025 Professional Services
- ocds-ted-7019-2025Avenier a.s.Kč123M07 Jan 2025 Professional Services
- ocds-ted-624411-2025Janssen-Cilag s.r.o.Kč105M24 Sep 2025 Professional Services
Other wins · Fresenius Kabi s.r.o.
264 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-240465-2025-5Všeobecná fakultní nemocnice v PrazeKč200M14 Apr 2025 Professional Services
- ocds-ted-428125-2025Fakultní nemocnice OstravaKč131M02 Jul 2025 Healthcare
- ocds-ted-146997-2026Fakultní nemocnice OstravaKč108M03 Mar 2026 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Revmatologický ústav and Fresenius Kabi s.r.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back